
NHS wasting hundreds of millions of pounds says Marsh
Speaking at a conference examining healthcare acquired infections (HAIs), Robert Wendin, Head of Marsh’s Healthcare Practice for Europe, the Middle East and Africa, said that hospitals which invest in MRSA prevention can demonstrate tangible financial returns.
Mr Wendin said: “The moral duty to patients already provides a clear reason to tackle MRSA. Our analysis shows that there is now a strong financial one as well. “We calculate that HAIs can cost an average 300-bed hospital over £1.5
Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.
To access these options, along with all other subscription benefits, please contact [email protected].
You are currently unable to print this content. Please contact [email protected] to find out more.
You are currently unable to copy this content. Please contact [email protected] to find out more.
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Printing this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email [email protected]
Copyright Infopro Digital Limited. All rights reserved.
You may share this content using our article tools. Copying this content is for the sole use of the Authorised User (named subscriber), as outlined in our terms and conditions - https://www.infopro-insight.com/terms-conditions/insight-subscriptions/
If you would like to purchase additional rights please email [email protected]
More on Regulation
Videos/Podcasts
Insurance Covid-Cast: How has staff productivity been impacted by remote working?
For the 35th episode of Post and Insurance Age’s video series we gathered together a panel of senior insurance managers to discuss how productive staff have been since Covid-19 lockdown, and whether it has changed as restrictions have eased?
Subscribe to our daily newsletter for all the latest news
Most read
- Blog: Could Aviva ever dominate the high net worth market?
- Analysis: The future of the networks model
- Partners& buys Nottingham-based broker
- Mulsanne accuses Marshmallow of stealing trade secrets in court battle
- Brokers may be failing to report misconduct
- People moves: 12-16 April 2021
- FCA data reveals progress as insurers settle Covid-19 BI claims